
COVID-19 concerns prompt Indianapolis library restrictions
Starting on Dec. 21, the Indianapolis Public Library’s branches will restrict in-person services to curbside pickup and limited computer use. Browsing for books won’t be permitted.
Starting on Dec. 21, the Indianapolis Public Library’s branches will restrict in-person services to curbside pickup and limited computer use. Browsing for books won’t be permitted.
The state of Indiana is set to receive more than 55,000 doses of the COVID-19 vaccine for health care workers next week, with the initial doses going to five pilot hospitals. By the end of next week, additional doses are expected at a total of 50 hospitals throughout the state.
The U.S. gave the final go-ahead Friday to the nation’s first COVID-19 vaccine, marking what could be the beginning of the end of an outbreak that has killed nearly 300,000 Americans.
Food and Drug Administration chief Stephen Hahn signaled that he would tell regulators to allow the vaccine to be issued on an emergency basis, White House chief of staff Mark Meadows said.
Doctors are reporting that a two-drug treatment involving a medication from Indianapolis-based Eli Lilly and Co. is especially helpful for COVID-19 patients who need extra oxygen.
COVID-19 relief talks remain stalled but there is universal agreement that Congress won’t adjourn for the year without passing a long-delayed round of pandemic relief.
The stock market tumbled through years’ worth of losses in just over a month this spring, only to turn around and pack an entire bull market’s worth of gains into less than nine months.
The earlier-than-usual deadlines come as more people turn to online shopping during the pandemic, creating a logjam for shipping companies as well as delivery delays. The U.S. Post Office admits that processing plants are “overwhelmed.”
Pollstar on Friday said the live events industry should have hit a record-setting $12.2 billion this year, but instead it incurred $9.7 billion in losses.
An emerging $900 billion COVID-19 aid package from a bipartisan group of lawmakers all but collapsed Thursday after Senate Majority Leader Mitch McConnell said Republican senators won’t support $160 billion in state and local funds as part of a potential trade-off in the deal.
The advisory group, in 17-4 vote with one abstention, concluded that the shot appears safe and effective against the coronavirus in people 16 and older.
He said he wanted to “add his voice to a chorus of fellow mayors” from across the state and country calling for Congress to take action.
The deficit—the shortfall between what the government collects in taxes and what it spends—reflected an 8.9% jump in outlays, to $886.6 billion, and a 2.9% decline in tax revenues, to $457.3 billion.
The latest figures coincide with a surging viral outbreak that appears to be weakening the job market and the economy and threatening to derail any recovery.
Wall Street has rolled out the welcome mat for companies going public this year, boosting proceeds from initial public offerings to the highest level in six years.
Amid the uncertainty, the House easily passed a one-week government-wide funding bill Wednesday that sets a new Dec. 18 deadline for Congress to wrap up both the COVID-19 relief measure and a $1.4 trillion catch-all spending bill that is also overdue.
Thursday’s meeting of the Food and Drug Administration’s vaccine advisory panel is likely the last step before a U.S. decision to begin shipping millions of doses of the shot, which has shown strong protection against the coronavirus.
Federal regulators on Wednesday sued to force a breakup of Facebook as 48 states and districts accused the company in a separate lawsuit of abusing its market power in social networking to crush smaller competitors.
British regulators warned Wednesday that people who have a history of serious allergic reactions shouldn’t receive the new Pfizer-BioNTech vaccine as they investigate two adverse reactions that occurred on the first day of the country’s mass vaccination program.
The $916 billion offer, the separate ongoing talks among key rank-and-file senators, and the shifting demands by the White House all add up to muddled, confusing prospects for a long-delayed COVID-19 aid package.